Form CERT - Certification by an exchange approving securities for listing:
SEC Accession No. 0001354457-20-000141
Filing Date
2020-04-06
Accepted
2020-04-06 12:15:38
Documents
1
Effectiveness Date
2020-04-06

Document Format Files

Seq Description Document Type Size
1 8A CERT 8A_Cert_KROS.pdf CERT 155718
  Complete submission text file 0001354457-20-000141.txt   212569
Mailing Address 99 HAYDEN AVENUE, SUITE 120 (BLD E) LEDGEMONT TECHNOLOGY CENTER LEXINGTON MA 02421
Business Address 99 HAYDEN AVENUE, SUITE 120 (BLD E) LEDGEMONT TECHNOLOGY CENTER LEXINGTON MA 02421 617-513-8774
Keros Therapeutics, Inc. (Filer) CIK: 0001664710 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: CERT | Act: 34 | File No.: 001-39264 | Film No.: 20776375
SIC: 2834 Pharmaceutical Preparations